ADAPTIMMUNE THERAPEUTICS PLC: capex
| Value | {"amount": 29496000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | ADAPTIMMUNE THERAPEUTICS PLC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:40:50.704147+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/77cbc77e-76cd-44b0-af8f-4d9542f4303c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-23-002907 · Open the official SEC filing →Retrieved: 2026-08-19T16:40:50.704147+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001621227/capex/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/77cbc77e-76cd-44b0-af8f-4d9542f4303c
History
- no predecessors — first report